October 1, 2024
TOPLINE: A unique glycosylation signature on circulating antibodies is detectable in blood up to 6 years before a diagnosis of Crohn’s disease and could serve as […]
September 30, 2024
TOPLINE: A new epigenetic assay is able to stratify patients with Barrett’s esophagus into lower-risk and higher-risk categories for progression to high-grade dysplasia or esophageal adenocarcinoma […]
September 25, 2024
In a review of 32 mixed-type human studies, multinational researchers found a growing association between various classes of environmental pollutants and the risk for inflammatory bowel […]
September 25, 2024
Unprecedented progress that poses new challenges, increased attention to the environment in which one eats, and a focus on diseases with a broad impact but where […]
September 24, 2024
Digital pathology assisted by artificial intelligence (AI) has the potential to transform the diagnosis and treatment of fibrotic liver disease in the next few years and […]
September 24, 2024
It may come as a surprise but Europe has a malnutrition problem. It affects millions of people, yet it is deeply underestimated and requires a shared […]
September 23, 2024
Meet your new patients. You can’t see them, but trillions — maybe quadrillions — of them travel in and out of your practice every day. They’re […]
September 20, 2024
TOPLINE: Stool-based tests for colorectal cancer (CRC) screening show no significant difference in detecting advanced neoplasia overall, but for advanced serrated lesions specifically, the multitarget stool […]
September 20, 2024
In July, the US Food and Drug Administration (FDA) approved the first blood-based test to screen for colorectal cancer (CRC). The FDA’s approval of Shield (Guardant […]